Broder MS - Search Results

1

A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies.

Ortendahl JD, Harmon AL, Bentley TGK, Broder MS. Ortendahl JD, et al. Among authors: broder ms. J Med Econ. 2017 Jul;20(7):767-775. doi: 10.1080/13696998.2017.1336449. Epub 2017 Jun 9. J Med Econ. 2017. PMID: 28562126 Free article. Review.

2

Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States.

Broder MS, Chang EY, Bentley TG, Juday T, Uy J. Broder MS, et al. J Med Econ. 2011;14(2):167-78. doi: 10.3111/13696998.2011.554932. Epub 2011 Feb 2. J Med Econ. 2011. PMID: 21288058 Free article.

3

Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches.

Broder MS, Juday T, Chang EY, Jing Y, Bentley TG. Broder MS, et al. Med Decis Making. 2012 Jan-Feb;32(1):118-31. doi: 10.1177/0272989X11403489. Epub 2011 Apr 21. Med Decis Making. 2012. PMID: 21512188

4

Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer.

Vanderlaan BF, Broder MS, Chang EY, Oratz R, Bentley TG. Vanderlaan BF, et al. Among authors: broder ms. Am J Manag Care. 2011;17(7):455-64. Am J Manag Care. 2011. PMID: 21819166 Free article.

5

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US.

Juday T, Correll T, Anene A, Broder MS, Ortendahl J, Bentley T. Juday T, et al. Among authors: broder ms. Clinicoecon Outcomes Res. 2013 Sep 2;5:437-45. doi: 10.2147/CEOR.S47486. eCollection 2013. Clinicoecon Outcomes Res. 2013. PMID: 24039438 Free PMC article.

6

Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer.

Bentley TG, Schroeder BE, Schnabel CA, Erlander MG, Hsiao WC, Ortendahl JD, Broder MS. Bentley TG, et al. Among authors: broder ms. J Med Econ. 2014 Aug;17(8):527-37. doi: 10.3111/13696998.2014.909817. Epub 2014 May 14. J Med Econ. 2014. PMID: 24689556 Free article.

7

Hospital cost and length of stay in idiopathic pulmonary fibrosis.

Mooney JJ, Raimundo K, Chang E, Broder MS. Mooney JJ, et al. Among authors: broder ms. J Med Econ. 2017 May;20(5):518-524. doi: 10.1080/13696998.2017.1282864. Epub 2017 Feb 3. J Med Econ. 2017. PMID: 28092235 Free article.

8

Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data.

Rosenblatt L, Broder MS, Bentley TGK, Chang E, Reddy SR, Papoyan E, Myers J. Rosenblatt L, et al. Among authors: broder ms. AIDS Care. 2017 Aug;29(8):1067-1073. doi: 10.1080/09540121.2017.1280123. Epub 2017 Feb 1. AIDS Care. 2017. PMID: 28147708

9

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs.

Bentley TGK, Cohen JT, Elkin EB, Huynh J, Mukherjea A, Neville TH, Mei M, Copher R, Knoth R, Popescu I, Lee J, Zambrano JM, Broder MS. Bentley TGK, et al. Among authors: broder ms. Value Health. 2017 Feb;20(2):200-205. doi: 10.1016/j.jval.2016.12.011. Epub 2017 Feb 10. Value Health. 2017. PMID: 28237195 Free article.

10

The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail.

Cogle CR, Kurtin SE, Bentley TG, Broder MS, Chang E, Megaffin S, Fruchtman S, Petrone ME, Mukherjee S. Cogle CR, et al. Among authors: broder ms. Oncologist. 2017 Apr;22(4):379-385. doi: 10.1634/theoncologist.2016-0211. Epub 2017 Mar 10. Oncologist. 2017. PMID: 28283585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page